Novo Nordisk shares plunge 22% after CagriSema obesity drug trial results ...United Arab Emirates

Economy by : (CNBC) -
Shares of Danish pharmaceutical giant Novo Nordisk plummeted more than 22% on Friday after reporting results in a late-stage trial that missed expectations.

Read More Details
Finally We wish PressBee provided you with enough information of ( Novo Nordisk shares plunge 22% after CagriSema obesity drug trial results )

Also on site :

Most Viewed Economy
جديد الاخبار